Statistically representative study in Schleswig-Holstein into COVID-19 secondary complications
Comorbidity of SARS-CoV-2 infections – impact on health status and quality of life
COVID-19 is a new viral disease that primarily affects the lungs, but during the acute stage already also affects numerous other organ systems, to a variable and as yet unpredictable extent. In light of the multiple organs involved, as well as the severity of the organ damage, it can be expected that significant chronic secondary complications will develop, which represent a significant burden for those affected as well as the healthcare system.
Quantifying secondary complications in a statistically representative manner
In order to be able to develop appropriate prevention and treatment strategies, it is essential to quantify the secondary complications in a manner which is statistically representative of the population. This requires a comprehensive follow-up examination of all those infected in a geographically defined area – in this case, the state of Schleswig-Holstein. To this end, the University Medical Center Schleswig-Holstein (UKSH) is carrying out a study into COVID-19 comorbidity, which is statistically representative of the population. The study will enable a detailed phenotyping of patients and their disease progression, as well as long-term case histories.
Building on many years of experience
As the sole provider of maximum care in the state, the University Medical Center Schleswig-Holstein (UKSH) is excellently positioned for COVIDOM, and together with the universities in Kiel and Lübeck has special expertise in the area of statistically representative cohort studies of patients with chronic diseases, but also of the healthy population in the state of Schleswig-Holstein.
Networking and partners
The COVIDOM comorbidity study is being conducted in close cooperation with the Robert Koch Institute (RKI) and the German Centres for Health Research (DZG), and in particular with the German Center for Pulmonary Research (DZL) and the German Center for Infection Research (DZIF). In addition, there is close coordination and collaboration with the Nationale COVID-19-Forschungsnetzwerk der deutschen Universitätsmedizin (National COVID-19 Research Network of German University Medicine, NaFoUniMed COVID19) initiated by the Federal Ministry of Education and Research (BMBF).
More information to follow soon…